InsiderClue
Stocks · Health care · Pharmaceutical Preparations

TEVA PHARMACEUTICAL INDUSTRIES LTD

TEVA Clue Score52
Israel Fiscal year ends December CIK 0000818686 Results filed 3 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

58
Insider
Date
Role
Action
Shares
Price
Amount
Roberto Mignone
18 Sep 2026
Director
Sell indirect
367,600
$39.06
$14.36M
Brian Savage
18 Sep 2026
Interim Chief Legal Officer
Sold after exercise
314
$38.70
$12.15K
Brian Savage
18 Sep 2026
Interim Chief Legal Officer
Sold after exercise
2,525
$39.15
$98.84K
Brian Savage
18 Sep 2026
Interim Chief Legal Officer
Sold after exercise
4,503
$38.69
$174.22K
Ronit Satchi-Fainaro
21 Aug 2026
Director
Sell
415
$37.25
$15.46K
Amir Weiss
21 Aug 2026
Chief Accounting Officer
Sold after exercise
2,500
$37.63
$94.08K
Amir Weiss
21 Aug 2026
Chief Accounting Officer
Sold after exercise
6,945
$37.61
$261.22K
Evan Lippman
17 Aug 2026
EVP, Business Development
Sold on a plan
18,600
$36.57
$680.29K
Tal Zvi Zaks
5 Aug 2026
Director
Sell
17
$34.87
$592.71
Eric A Hughes
3 Aug 2026
See "Remarks"
Sold after exercise
25,578
$34.88
$892.05K
Placid Jover
3 Aug 2026
See "Remarks"
Sold after exercise
12,827
$34.88
$447.35K
Matthew Shields
18 Jun 2026
EVP, Global Operations
Sell
9,989
$32.19
$321.55K
Eliyahu Sharon Kalif
11 Jun 2026
EVP, Chief Financial Officer
Sold on a plan
106,563
$34.10
$3.63M
Richard D Francis
5 Jun 2026
President and CEO
Sold after exercise
6,153
$34.35
$211.36K
Matthew Shields
3 Jun 2026
EVP, Global Operations
Sold after exercise
16,195
$32.87
$532.33K
Eliyahu Sharon Kalif
14 May 2026
EVP, Chief Financial Officer
Sold on a plan
153,251
$35.61
$5.46M
Evan Lippman
14 May 2026
EVP, Business Development
Sold after exercise
35,912
$35.58
$1.28M
Evan Lippman
14 May 2026
EVP, Business Development
Sold after exercise
5,746
$35.58
$204.47K
Amir Weiss
6 May 2026
Chief Accounting Officer
Sell
10,679
$36.00
$384.44K
Richard Daniell
5 May 2026
EVP, Europe Commercial
Sell
30,000
$35.40
$1.06M
Mark Sabag
1 May 2026
See "Remarks"
Sell
144,180
$34.99
$5.05M
Christine Fox
30 Apr 2026
EVP, U.S. Commercial
Sell
21,258
$35.31
$750.62K
Mark Sabag
17 Mar 2026
See "Remarks"
Sell
62,102
$30.14
$1.87M
Matthew Shields
5 Mar 2026
EVP, Global Operations
Sold after exercise
17,295
$31.67
$547.70K
Brian Savage
5 Mar 2026
Interim Chief Legal Officer
Sold after exercise
1,127
$31.67
$35.69K
Placid Jover
5 Mar 2026
See "Remarks"
Sold after exercise
14,150
$31.67
$448.11K
Richard Daniell
5 Mar 2026
EVP, Europe Commercial
Sold after exercise
17,295
$31.67
$547.70K
Eric A Hughes
5 Mar 2026
See "Remarks"
Sold after exercise
9,533
$31.67
$301.89K
Christine Fox
5 Mar 2026
EVP, U.S. Commercial
Sold after exercise
7,924
$31.67
$250.94K
Richard D Francis
5 Mar 2026
President and CEO
Sold after exercise
20,025
$31.67
$634.16K
Brian Savage
4 Mar 2026
Interim Chief Legal Officer
Sold after exercise
1,186
$32.46
$38.50K
Brian Savage
4 Mar 2026
Interim Chief Legal Officer
Sold after exercise
1,489
$32.46
$48.34K
Christine Fox
4 Mar 2026
EVP, U.S. Commercial
Sold after exercise
9,098
$32.46
$295.36K
Eric A Hughes
4 Mar 2026
See "Remarks"
Sold after exercise
11,277
$32.46
$366.10K
Richard Daniell
4 Mar 2026
EVP, Europe Commercial
Sold after exercise
37,372
$32.95
$1.23M
Richard Daniell
4 Mar 2026
EVP, Europe Commercial
Sold after exercise
20,461
$32.46
$664.26K
Richard Daniell
4 Mar 2026
EVP, Europe Commercial
Sold after exercise
33,512
$32.46
$1.09M
Richard D Francis
4 Mar 2026
President and CEO
Sold after exercise
23,393
$32.46
$759.44K
Eric A Hughes
3 Mar 2026
See "Remarks"
Sold after exercise
68,685
$32.36
$2.22M
Eric A Hughes
3 Mar 2026
See "Remarks"
Sold after exercise
12,077
$32.36
$390.81K
Richard D Francis
3 Mar 2026
President and CEO
Sold after exercise
412,032
$32.36
$13.33M
Richard D Francis
3 Mar 2026
President and CEO
Sold after exercise
30,903
$32.36
$1.00M
Brian Savage
3 Mar 2026
Interim Chief Legal Officer
Sold after exercise
1,274
$32.36
$41.23K
Richard Daniell
3 Mar 2026
EVP, Europe Commercial
Sold after exercise
66,735
$32.36
$2.16M
Richard Daniell
3 Mar 2026
EVP, Europe Commercial
Sold after exercise
62,250
$32.36
$2.01M
Eliyahu Sharon Kalif
26 Feb 2026
EVP, Chief Financial Officer
Sold on a plan
345,810
$33.64
$11.63M
Richard D Francis
15 Feb 2026
President and CEO
Sold after exercise
286,122
$34.22
$9.79M
Richard D Francis
15 Feb 2026
President and CEO
Sold after exercise
161,656
$34.22
$5.53M
Roberto Mignone
16 Dec 2025
Director
Sell indirect
77,400
$30.24
$2.34M
Amir Weiss
16 Dec 2025
Chief Accounting Officer
Sell
12,300
$30.20
$371.50K
Mark Sabag
9 Dec 2025
See "Remarks"
Sold after exercise
98,168
$28.70
$2.82M
Mark Sabag
9 Dec 2025
See "Remarks"
Sold after exercise
118,724
$28.75
$3.41M
Richard Daniell
9 Dec 2025
Exec. VP, European Commercial
Sold after exercise
115,468
$28.68
$3.31M
Roberto Mignone
26 Nov 2025
Director
Sell indirect
50,000
$26.03
$1.30M
Christine Fox
20 Nov 2025
EVP, Head of U.S. Commercial
Sold after exercise
28,229
$24.78
$699.52K
Christine Fox
14 Nov 2025
EVP, Head of U.S. Commercial
Sell
30,000
$25.11
$753.32K
Amir Weiss
6 Nov 2025
Chief Accounting Officer
Sell
12,300
$24.44
$300.56K
Roberto Mignone
6 Nov 2025
Director
Sell indirect
200,000
$24.11
$4.82M

What was left out

Form 4 filings counted 82
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 39
Sales at will 15
Transactions with no price 0
Shares from compensation/vesting 3,557,282
History held since 24 Jul 2008